Ularitide

SCHEMBL29484210

CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	NPR1	P16066	1/20	0.79

▸	NPR3	P17342	1/20	0.79

▸	RXFP4	Q8TDU9	5/20	0.61

▸	RXFP3	Q9NSD7	5/20	0.61

▸	INSR	P06213	1/20	0.58

▸	NPY2R	P49146	7/20	0.58

▸	MC4R	P32245	1/20	0.58

▸	MC1R	Q01726	1/20	0.58

▸	F11	P03951	2/20	0.56

▸	KCNA3	P22001	1/20	0.56

▸	KCNA1	Q09470	1/20	0.56

▸	KLK7	P49862	2/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Ularitide SCHEMBL27908491	1.00	NPR1 (0.79)	NPR1NPR3RXFP4RXFP3INSR
Ularitide SCHEMBL29357163	0.94	NPR1 (0.71)	NPR1NPR3RXFP4RXFP3INSR
SCHEMBL29689331	0.92	NPR1 (0.77)	NPR1NPR3RXFP4RXFP3INSR
Carperitide SCHEMBL218549	0.92	NPR1 (0.94)	NPR1NPR3RXFP4RXFP3INSR
Acetic Acid SCHEMBL29363649	0.90	NPR1 (0.87)	NPR1NPR3INSRMC4RMC1R
SCHEMBL29376235	0.89	NPR1 (0.88)	NPR1NPR3RXFP4RXFP3INSR
SCHEMBL29711548	0.88	NPR1 (0.86)	NPR1NPR3RXFP4RXFP3INSR
Hydrochloric Acid SCHEMBL29495482	0.87	NPR1 (0.85)	NPR1NPR3RXFP4RXFP3INSR
SCHEMBL31332082	0.85	NPR1 (0.78)	NPR1NPR3MC4RMC1RF11
SCHEMBL29379928	0.84	NPR1 (0.78)	NPR1NPR3INSRMC4RMC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3805246-B1	METHOD FOR PURIFYING LONG CHAIN POLYPEPTIDE ULARITIDE	HYBIO PHARMACEUTICAL CO LTD (CN)	2025-02-19	—	—	EP	disclosed
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed
US-11312744-B2	Method for purifying long chain polypeptide	Hybio Pharmaceutical Co., Ltd. (CN)	2022-04-26	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11312744-B2	Method for purifying long chain polypeptide	VIP, SPPL2A, PSAP	NPR1 119/4885NPR3 194/4885RXFP4 979/4885
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	NPR1 21/4885NPR3 39/4885RXFP4 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.